Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.15
Delayed Data
As of Jun 28
 +0.50 / +3.00%
Today’s Change
8.31
Today|||52-Week Range
32.74
+18.11%
Year-to-Date
Valeant Could be Worth 30% More If It Can Continue to Execute Turnaround Efforts
Jun 28 / TheStreet.com - Paid Partner Content
Paulson Ups Valeant Stake; Activist Investor Targets Nestle -- ICYMI Monday
Jun 26 / TheStreet.com - Paid Partner Content
Saba Capital Management, L.P. Buys Clough Global Opportunities Fund, General American...
Jun 28 / GuruFocus News - Paid Partner Content
The Good, the Bad and the Ugly (Monday Edition)
Jun 26 / TheStreet.com - Paid Partner Content
Paulson Dives Deeper Into Valeant With Increased Holding
Jun 27 / GuruFocus News - Paid Partner Content
These Stocks Are Changing Course
Jun 26 / TheStreet.com - Paid Partner Content
Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?
Jun 27 / Zacks.com - Paid Partner Content
Company News for June 20, 2017
Jun 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close16.65
Today’s open17.00
Day’s range16.75 - 17.23
Volume22,072,177
Average volume (3 months)23,422,886
Market cap$5.7B
Dividend yield--
Data as of 4:01pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-34.14%
Earnings growth (next 5 years)-1.55%
Revenue growth (last year)-7.39%
P/E ratioNM
Price/Sales0.52
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.04-0.19%
UTHRUnited Therapeutics ...+1.36+1.04%
PTHNPatheon NV+0.01+0.03%
IONSIonis Pharmaceutical...+1.44+2.74%
Data as of 4:02pm ET, 06/28/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.96
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts